Publications by authors named "Riddhi Sawant"
J Clin Oncol
January 2023
Article Synopsis
- - The study explored the effectiveness of adding low-dose nivolumab to a triple metronomic chemotherapy (TMC) regimen for patients with advanced head and neck squamous cell carcinoma, aiming to improve overall survival (OS) among those unable to afford conventional treatments.
- - Results showed that adding low-dose nivolumab significantly increased the one-year OS rate from 16.3% to 43.4% and improved the median OS from 6.7 months to 10.1 months when compared to TMC alone.
- - This research is notable as it is the first randomized trial demonstrating that low-dose nivolumab combined with metronomic chemotherapy can serve as a viable alternative for patients lacking access to conventional therapies
